Regular short-acting β(2)-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring.
- DOI
- 10.1016/j.hrtlng.2026.102789
- Published
- 2026 Sep-Oct
- Container
- Heart & lung : the journal of critical care
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.hrtlng.2026.102789,
title = {Regular short-acting β(2)-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring.},
author = {Csonka LL and Vähätalo I and Ilmarinen P and Tuomisto LE and Kankaanranta H and Lehtimäki L},
year = {2026},
journal = {Heart \& lung : the journal of critical care},
doi = {10.1016/j.hrtlng.2026.102789},
url = {https://doi.org/10.1016/j.hrtlng.2026.102789}
}RIS
TY - JOUR TI - Regular short-acting β(2)-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring. AU - Csonka LL AU - Vähätalo I AU - Ilmarinen P AU - Tuomisto LE AU - Kankaanranta H AU - Lehtimäki L PY - 2026 JO - Heart & lung : the journal of critical care DO - 10.1016/j.hrtlng.2026.102789 UR - https://doi.org/10.1016/j.hrtlng.2026.102789 ER -
APA
LL, C., I, V., P, I., LE, T., H, K., & L, L. (2026). Regular short-acting β(2)-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring.. Heart & lung : the journal of critical care. https://doi.org/10.1016/j.hrtlng.2026.102789
Source records
- pubmed · retrieved 2026-09-27T09:11:03.907Z